Rilzabrutinib granted FDA fast track designation for treatment of immune thrombocytopenia
Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Nov 19, 2020 at 11:13 AM.
Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Nov 19, 2020 at 11:13 AM.